ARPA-H Announces $125M in Awards to Advance AI for Rare Diseases and Personalized RNA-based Medicines

ARPA-H will fund up to $125M through its GIVE program to advance a new manufacturing model for individualized, RNA-based genetic medicines. Among the awardees, Seattle-based HDT Bio will develop an integrated platform combining automated DNA synthesis, RNA production, closed fill-finish, and robotics-enabled quality control testing